Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Human pluripotent stem cells have been shown to be important models for interrogating the molecular basis for heart disease. This review highlights the contributions of these models to our understanding of inherited arrhythmia syndromes, with a focus on integrating mechanistic and genome-wide association study data.
Based on the 19th Global Cardiovascular Clinical Trialists meeting, this Perspective discusses potential sources of evidence that may be used to complement explanatory phase 3 randomized clinical trials and accelerate the development of new cardiovascular medications.
Barisano et al. discuss how vascular dysfunction caused by blood–brain barrier breakdown interacts with amyloid beta and tau AD biomarkers and may predict early cognitive impairment, dementia and Alzheimer’s disease.
